Concord Biotech IPO Date, Review, Price, Allotment Details

Concord Biotech IPO Details: Concord Biotech IPO date is fixed, the IPO is to hit the market on August 4 and will close on August 8, 2023. Concord Biotech IPO to raise around ₹1551 crores via IPO that comprises offer for sale up to 20,925,652 equity shares ₹10 each. The retail quota is 35%, QIB is 50%, and HNI is 15%.
Concord Biotech IPO

Table of Contents

Concord Biotech Limited is an R&D-driven biopharma Company based in Ahmedabad. They are one of the leading global developers and manufacturers of Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. Concord Biotech has a global presence in more than 70 countries worldwide with efficient distribution infrastructure in markets like the USA, Europe, Japan, Latin America, Africa, and Asia, besides a significant presence in the Indian market. Concord is actively expanding its horizons by partnering with leading global pharmaceutical companies by meeting their product development needs for APIs & finished formulations.

They have six fermentation-based immunosuppressant APIs, including tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus. Their aim is to continue to grow their immunosuppressant API portfolio, which will remain one of the key contributors to the API business in the near future. In addition to our immunosuppressant API portfolio, they aim to increase APIs sales across other therapeutic areas, especially the (i) Anti-infective APIs. Our anti-infective APIs (ii) Oncology drug APIs. They offer six oncology drug APIs, including temsirolimus, everolimus, romidepsin, mitomycin, dactinomycin, and midostaurin.

As of March 31, 2022, they had 22 API products. They have three manufacturing facilities in the state of Gujarat, India. They have established two DSIR-approved R&D units with 163 members as of March 31, 2022. They have over 200 customers in over 70 countries as of March 31, 2022, for their APIs and formulations. They also entered into long-term supply agreements with some of our customers. Their API customers include Intas Pharmaceuticals Limited and Glenmark Pharmaceuticals Limited.

Objects of the Issue

  • Achieve the benefits of listing Equity Shares on the Stock Exchanges
  • Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.

Concord Biotech IPO Review (Apply or Not)

  • May Apply

Brokerage Firm IPO Review

  • Capital Market: To be updated soon
  • Religare Broking: To be updated soon
  • Hem Securities: To be updated soon
  • Arihant Capital: To be updated soon

Concord Biotech IPO Date & Price Band Details

IPO Open:August 4, 2023
IPO Close:August 8, 2023
IPO Size:Approx ₹1551 Crores
Offer for Sale:Approx 20,925,652 Equity Shares
Face Value:₹1 Per Equity Share
IPO Price Band:₹705 to ₹741 Per Share
IPO Listing on:BSE & NSE
Retail Quota:35%
QIB Quota:50%
 NII Quota:15%
DRHP Draft Prospectus:Click Here
RHP Draft Prospectus:Click Here
Anchor Investors List:Click Here

Concord Biotech IPO Market Lot

The Concord Biotech IPO minimum market lot is 20 shares with ₹14,820 application amount. The retail investors can apply up-to 13 lots with 260 shares or ₹192,660 amount.

ApplicationLot SizeSharesAmount
Retail Minimum120₹14,820
Retail Maximum13260₹192,660
S-HNI Minimum14280₹207,480
B-HNI Minimum681360₹1,007,760

Concord Biotech IPO Allotment & Listing Dates

The Concord Biotech IPO date is August 4 and the close date is August 8. The Concord Biotech IPO allotment will be finalized on August 11 and the IPO listing on August 18.

Price Band Announcement:July 31, 2023
Anchor Investors Allotment:August 3, 2023
IPO Open Date:August 4, 2023
IPO Close Date:August 8, 2023
Basis of Allotment:August 11, 2023
Refunds:August 14, 2023
Credit to Demat Account:August 17, 2023
IPO Listing Date:August 18, 2023

You can check IPO subscription status and IPO allotment status on their respective pages.

Concord Biotech IPO Form

How to apply for the Concord Biotech IPO? You can apply for Concord Biotech IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Concord Biotech IPO in the Invest section. The other option is you can apply for Concord Biotech IPO via IPO forms downloaded via NSE and BSE. Check out the Concord Biotech forms – Click BSE Forms & NSE Forms blank IPO forms download, fill, and submit in your bank or with your broker.

Concord Biotech Company Financial Report

  ₹ in Crores

Concord Biotech IPO Valuation – FY2023

Check Concord Biotech IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.

Earning Per Share (EPS):₹22.95 per Equity Share
Price/Earning P/E Ratio:N/A
Return on Net Worth (RoNW):20.06%
Net Asset Value (NAV):₹123.31 per Equity Share

Peer Group

  • Divi’s Laboratories Limited
  • Suven Pharmaceuticals Limited
  • Laurus Labs Limited
  • Shilpa Medicare Limited

Company Promoters


Concord Biotech IPO Registrar

Link Intime India Private Limited
Tel: +91 22 4918 6200
E-mail: [email protected]

Concord Biotech IPO Allotment Status Check

Check Concord Biotech IPO allotment status on Linkintime website allotment URL. Click Here

Concord Biotech IPO Lead Managers aka Merchant Bankers

  • Kotak Mahindra Capital Company Limited
  • Citigroup Global Markets India Private Limited
  • Jefferies India Private Limited

Company Address

Concord Biotech Limited
1482-86, Trasad Road, Dholka,
Ahmedabad – 382225, Gujarat, India
E-mail: [email protected]

Concord Biotech IPO FAQs

What is Concord Biotech IPO?

Concord Biotech IPO is a main-board IPO. They are going to raise ₹1551 Crores via IPO. The issue is priced at ₹705 to ₹741 pr equity share. The IPO is to be listed on BSE & NSE.

When Concord Biotech IPO will open?

The IPO is to open on August 4, 2023 for QIB, NII, and Retail Investors.

What is Concord Biotech IPO Investors Portion?

The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.

How to Apply the Concord Biotech IPO?

You can apply for Concord Biotech IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.

How to Apply the Concord Biotech IPO through Zerodha?

Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Concord Biotech”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.

How to Apply the Concord Biotech IPO through Upstox?

Log in to the Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Concord Biotech”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.

How to Apply the Concord Biotech IPO through Paytm Money?

Log in to Paytm Money Application with your credentials. Select the IPO. You will see the IPO Name “Concord Biotech”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Paytm Money.

What is Concord Biotech IPO Size?

Concord Biotech IPO size is ₹1551 crores.

What is Concord Biotech IPO Price Band?

Concord Biotech IPO Price Band is ₹705 to ₹741.

What is Concord Biotech IPO Minimum and Maximum Lot Size?

The minimum bid is 20 Shares with ₹14,820 amount while the maximum bid is 260 shares with ₹192,660.

What is the Concord Biotech IPO Allotment Date?

Concord Biotech IPO allotment date is August 11, 2023.

What is the Concord Biotech IPO Listing Date?

Concord Biotech IPO listing date is August 18, 2023. The IPO is to list on BSE and NSE.

Note: The Concord Biotech IPO price band and date are officially announced. The IPO grey market premium (Concord Biotech IPO Premium) will be added to the IPO grey market page as it will start).

Follow IPO Watch for the Upcoming IPO news and their reviews, also keep following us on TwitterFacebook, and Instagram. For our latest videos, subscribe to our YouTube channel.

Read Also:

Share the Post:

Leave a Reply

Your email address will not be published. Required fields are marked *